Completed NA INTERVENTIONAL 2-arm NCT02773095

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

Sponsor: Boston University

Conditions Asthma Breast Cancer Cardiovascular Disease Diabetes Type II

Updated 10 times since 2017 Last updated: Apr 27, 2020 Started: Jun 30, 2016 Primary completion: Nov 30, 2019 Completion: Nov 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Asthma and Breast Cancer and is currently completed. Boston University leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
May 2020 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Feb 2020 — May 2020 [monthly]

Active Not Recruiting NA

▶ Show 5 earlier versions

Jul 2019 — Feb 2020 [monthly]

Active Not Recruiting NA
Dec 2018 — Jul 2019 [monthly]

Active Not Recruiting NA
Jun 2018 — Dec 2018 [monthly]

Active Not Recruiting NA
Dec 2017 — Jun 2018 [monthly]

Active Not Recruiting NA
Jan 2017 — Dec 2017 [monthly]

Active Not Recruiting NA

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boston University
Innovations for Poverty Action

Data source: Boston University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.